Cell Viability Assays Market Trends

Growth Drivers

• Growing Geriatric Population- By 2030, one in six people on the earth would be 60 years of age or older, according to the World Health Organisation. There will likely be 1.4 billion persons who are 60 years of age or older by 2022, up from 1 billion in 2020. Cells make up the majority of tissues. All cells alter as they become older. They are growing larger while losing the ability to divide and multiply. Inside the cells, there are a number of pigments and fatty substances as well as other modifications. With increasing age, many of the cells stop functioning properly or start working in an unnatural way.
• Rise in Prevalence of Cancer- During the forecast period, an increase in cancer patients is anticipated. According to the World Health Organization, almost 10 million deaths, or roughly one in six deaths, would be caused by cancer in 2020, making it the top cause of death globally.
• Surge in Need for Stem Cell Transplant- A total of 12,000 stem cell transplants have taken place around the world in the last 50 years. Around 49,000 transplants have already been performed each year, and the number is growing.

Challenges

• Shortage of Technical Specialists and Professionals to Run Instruments- The global shortage of healthcare professionals can be attributed to the fact that many countries do not invest in health worker education and training. The lack of alignment between employment and education policies in view of the needs of workers and healthcare systems is also a major issue. The situation has deteriorated further since healthcare personnel is difficult to bring into remote, underutilised areas and in the countryside. In addition, there has been an increase of health workers' migration that could lead to a shortage in particular for poor and less well-developed countries.
• Assays for the Viability of Cells are very Expensive which may Hinder the Growth of the Market
• Misunderstanding of People's Awareness is One of the Retraining Factor